Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00138125
Status:
TERMINATED
Last Update Posted:
2020-10-19
First Post:
2005-08-29
Brief Title:
Fulvestrant andor Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer
Sponsor:
Organization:
Translational Oncology Research International